Nifty
:
19523.55
Sensex
:
65508.32
-192.90 (-0.98%)
-610.37 (-0.92%)
Nifty
Sensex
:
:
19523.55
65508.32
-192.90 (-0.98%)
-610.37 (-0.92%)

Nectar Lifesciences Ltd.

Pharmaceuticals & Drugs - Global

Rating :
37/99

BSE: 532649 | NSE: NECLIFE

NSE BSE
25.10
28-Sep-2023
  • Open
  • High
  • Low
  • Previous Close
  •  25.00
  •  25.90
  •  24.80
  •  24.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  236794
  •  59.38
  •  30.90
  •  14.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 559.76
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,296.00
  • N/A
  • 0.52

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.80%
  • 1.55%
  • 24.61%
  • FII
  • DII
  • Others
  • 16%
  • 0.02%
  • 2.02%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.72
  • -11.35
  • -0.43

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -15.57
  • -27.47
  • -12.18

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -30.89

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.48
  • 6.04
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.58
  • 0.44
  • 0.51

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.44
  • 8.12
  • 10.16

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Net Sales
394.12
403.02
-2.21%
388.81
476.23
-18.36%
344.13
443.00
-22.32%
388.65
364.57
6.61%
Expenses
358.58
361.22
-0.73%
370.73
427.08
-13.19%
342.68
396.41
-13.55%
396.04
337.11
17.48%
EBITDA
35.54
41.81
-15.00%
18.09
49.15
-63.19%
1.45
46.59
-96.89%
-7.40
27.46
-
EBIDTM
7.88%
8.97%
4.05%
8.98%
0.37%
9.08%
-1.65%
6.54%
Other Income
0.47
0.36
30.56%
17.93
0.52
3,348.08%
13.24
0.53
2,398.11%
10.71
5.10
110.00%
Interest
17.62
21.37
-17.55%
19.66
17.43
12.79%
17.46
17.62
-0.91%
20.99
18.01
16.55%
Depreciation
15.33
14.69
4.36%
14.85
14.26
4.14%
14.78
14.28
3.50%
14.79
14.15
4.52%
PBT
3.06
6.11
-49.92%
1.50
17.98
-91.66%
-17.56
15.22
-
-32.47
0.39
-
Tax
1.24
2.21
-43.89%
-2.17
6.32
-
-8.27
5.49
-
-10.00
-1.47
-
PAT
1.82
3.90
-53.33%
3.68
11.66
-68.44%
-9.29
9.73
-
-22.47
1.86
-
PATM
0.40%
0.84%
0.82%
2.13%
-2.40%
1.90%
-5.02%
0.44%
EPS
0.08
0.17
-52.94%
0.16
0.52
-69.23%
-0.41
0.43
-
-1.00
0.08
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
1,515.71
1,523.67
1,668.83
1,543.30
2,366.38
2,782.86
1,876.26
1,643.70
1,675.69
1,643.64
1,638.31
Net Sales Growth
-10.14%
-8.70%
8.13%
-34.78%
-14.97%
48.32%
14.15%
-1.91%
1.95%
0.33%
 
Cost Of Goods Sold
1,148.85
1,159.29
1,223.13
1,157.12
1,858.61
2,217.71
1,367.01
1,154.31
1,174.12
1,141.33
1,154.68
Gross Profit
366.86
364.38
445.70
386.19
507.77
565.16
509.25
489.39
501.57
502.31
483.63
GP Margin
24.20%
23.91%
26.71%
25.02%
21.46%
20.31%
27.14%
29.77%
29.93%
30.56%
29.52%
Total Expenditure
1,468.03
1,470.66
1,510.29
1,441.84
2,146.68
2,518.70
1,640.10
1,419.29
1,436.94
1,376.73
1,350.44
Power & Fuel Cost
-
127.39
101.41
84.63
92.72
103.47
91.85
75.44
87.89
79.60
66.10
% Of Sales
-
8.36%
6.08%
5.48%
3.92%
3.72%
4.90%
4.59%
5.25%
4.84%
4.03%
Employee Cost
-
75.13
71.91
70.59
78.19
76.55
74.65
75.54
78.38
58.93
47.97
% Of Sales
-
4.93%
4.31%
4.57%
3.30%
2.75%
3.98%
4.60%
4.68%
3.59%
2.93%
Manufacturing Exp.
-
45.32
45.56
44.64
46.88
50.38
52.90
53.32
39.56
37.05
33.57
% Of Sales
-
2.97%
2.73%
2.89%
1.98%
1.81%
2.82%
3.24%
2.36%
2.25%
2.05%
General & Admin Exp.
-
19.35
18.36
20.74
20.15
21.82
23.02
20.07
20.36
21.60
22.03
% Of Sales
-
1.27%
1.10%
1.34%
0.85%
0.78%
1.23%
1.22%
1.22%
1.31%
1.34%
Selling & Distn. Exp.
-
42.87
48.03
50.82
46.37
45.66
28.72
39.00
35.24
35.25
24.71
% Of Sales
-
2.81%
2.88%
3.29%
1.96%
1.64%
1.53%
2.37%
2.10%
2.14%
1.51%
Miscellaneous Exp.
-
1.32
1.90
13.31
3.76
3.12
1.95
1.61
1.41
2.97
24.71
% Of Sales
-
0.09%
0.11%
0.86%
0.16%
0.11%
0.10%
0.10%
0.08%
0.18%
0.08%
EBITDA
47.68
53.01
158.54
101.46
219.70
264.16
236.16
224.41
238.75
266.91
287.87
EBITDA Margin
3.15%
3.48%
9.50%
6.57%
9.28%
9.49%
12.59%
13.65%
14.25%
16.24%
17.57%
Other Income
42.35
43.18
11.32
11.38
4.36
6.04
6.04
22.67
5.78
20.00
12.53
Interest
75.73
79.49
78.81
112.03
125.83
148.13
115.20
117.41
123.31
125.59
137.99
Depreciation
59.75
59.12
56.97
60.25
60.77
63.26
64.31
62.25
57.39
76.56
84.19
PBT
-45.47
-42.42
34.08
-59.45
37.47
58.82
62.68
67.42
63.83
84.75
78.23
Tax
-19.20
-18.24
9.03
-11.50
5.68
11.22
10.41
12.08
9.59
18.49
16.14
Tax Rate
42.23%
43.00%
26.50%
13.57%
15.16%
19.08%
16.61%
17.92%
15.02%
21.82%
20.63%
PAT
-26.26
-24.18
25.05
-73.26
31.79
47.60
52.27
55.34
54.24
66.26
62.09
PAT before Minority Interest
-26.26
-24.18
25.05
-73.26
31.79
47.60
52.27
55.34
54.24
66.26
62.09
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-1.73%
-1.59%
1.50%
-4.75%
1.34%
1.71%
2.79%
3.37%
3.24%
4.03%
3.79%
PAT Growth
-196.72%
-
-
-
-33.21%
-8.93%
-5.55%
2.03%
-18.14%
6.72%
 
EPS
-1.47
-1.36
1.40
-4.11
1.78
2.67
2.93
3.10
3.04
3.72
3.48

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
1,064.59
1,087.90
1,062.03
1,136.13
1,105.16
1,058.66
1,006.68
954.08
957.95
927.06
Share Capital
22.43
22.43
22.43
22.43
22.43
22.43
22.43
22.43
22.43
22.43
Total Reserves
1,042.17
1,065.48
1,039.60
1,113.70
1,082.73
1,036.23
984.25
931.65
935.52
904.64
Non-Current Liabilities
213.12
296.29
126.41
249.29
299.92
355.84
295.58
362.30
396.92
340.94
Secured Loans
213.16
280.80
127.46
120.00
164.40
218.21
161.20
243.44
264.36
222.59
Unsecured Loans
13.31
10.28
0.78
1.48
1.19
1.87
2.60
1.96
1.17
0.75
Long Term Provisions
6.45
6.39
7.74
8.20
9.36
9.07
8.49
6.91
6.01
4.90
Current Liabilities
890.93
1,003.83
1,187.39
1,247.89
1,299.91
1,309.32
1,278.66
1,239.95
1,155.60
1,126.07
Trade Payables
318.75
376.65
342.15
527.14
483.67
539.42
528.10
496.78
455.58
440.06
Other Current Liabilities
111.40
122.71
131.63
95.44
170.40
123.40
106.88
107.95
90.50
86.72
Short Term Borrowings
458.91
502.77
712.00
619.71
635.97
634.08
630.34
627.24
595.30
579.84
Short Term Provisions
1.86
1.70
1.61
5.59
9.87
12.41
13.34
7.98
14.22
19.45
Total Liabilities
2,168.64
2,388.02
2,375.83
2,633.31
2,704.99
2,723.82
2,580.92
2,556.33
2,510.47
2,394.07
Net Block
661.97
723.10
771.89
784.85
824.82
852.35
881.24
905.58
933.73
947.54
Gross Block
1,557.96
1,562.95
1,555.70
1,508.82
1,490.49
1,456.36
1,363.67
1,383.66
1,451.42
1,341.15
Accumulated Depreciation
895.99
839.85
783.81
723.97
665.68
604.00
482.43
478.08
517.69
393.61
Non Current Assets
937.46
1,033.18
1,137.01
1,018.15
1,035.96
1,063.21
1,085.05
1,091.92
1,105.54
1,156.72
Capital Work in Progress
77.78
85.10
98.63
115.00
99.55
99.79
102.11
99.35
91.31
122.26
Non Current Investment
0.24
0.24
0.24
0.24
0.27
0.27
0.27
0.27
0.15
0.05
Long Term Loans & Adv.
9.31
9.76
12.17
115.07
108.33
104.19
96.90
82.24
80.34
86.87
Other Non Current Assets
188.16
214.99
254.08
2.99
2.99
6.61
4.53
4.47
0.00
0.00
Current Assets
1,231.18
1,354.85
1,238.83
1,615.16
1,669.03
1,660.61
1,495.86
1,464.42
1,369.02
1,237.34
Current Investments
0.31
0.46
0.46
0.17
0.51
0.51
0.41
0.52
0.44
0.31
Inventories
672.60
659.86
587.89
977.55
917.97
859.43
854.65
836.71
790.98
758.43
Sundry Debtors
279.61
446.98
374.83
395.87
558.73
611.97
499.73
491.45
446.50
376.65
Cash & Bank
17.58
17.81
25.54
21.29
21.33
9.31
13.18
36.65
33.38
9.98
Other Current Assets
261.08
67.05
51.67
70.52
170.50
179.38
127.89
99.09
97.73
91.97
Short Term Loans & Adv.
165.03
162.69
198.45
149.76
98.69
124.56
74.01
67.55
84.61
69.02
Net Current Assets
340.26
351.02
51.44
367.27
369.13
351.29
217.20
224.47
213.42
111.27
Total Assets
2,168.64
2,388.03
2,375.84
2,633.31
2,704.99
2,723.82
2,580.91
2,556.34
2,510.47
2,394.07

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
133.65
95.00
21.38
284.96
239.24
65.17
198.76
168.82
144.41
254.87
PBT
-42.42
34.08
-84.77
37.47
58.82
62.68
67.42
64.74
84.75
78.22
Adjustment
98.15
125.47
150.40
186.46
207.17
175.82
158.85
174.16
185.24
212.94
Changes in Working Capital
77.92
-64.54
-40.54
70.36
-13.19
-160.72
-20.34
-61.52
-119.29
-16.31
Cash after chg. in Working capital
133.65
95.00
25.09
294.29
252.79
77.79
205.93
177.38
150.70
274.85
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
-3.71
-9.33
-13.56
-12.62
-7.17
-8.56
-6.29
-19.98
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
51.70
16.64
-28.62
-33.13
-26.13
-29.43
-18.10
-76.88
-59.53
-89.99
Net Fixed Assets
12.31
6.28
-30.51
-33.78
-33.89
-90.37
17.23
59.72
-79.32
-101.53
Net Investments
0.48
0.00
-0.29
0.37
0.00
-0.10
0.11
-0.53
-0.23
0.01
Others
38.91
10.36
2.18
0.28
7.76
61.04
-35.44
-136.07
20.02
11.53
Cash from Financing Activity
-185.58
-119.38
11.49
-251.87
-201.09
-39.60
-204.12
-88.68
-61.47
-161.14
Net Cash Inflow / Outflow
-0.23
-7.73
4.25
-0.03
12.02
-3.87
-23.47
3.27
23.40
3.74
Opening Cash & Equivalents
17.81
25.54
21.29
21.33
9.31
13.18
36.65
33.38
9.98
6.24
Closing Cash & Equivalent
17.58
17.81
25.54
21.29
21.33
9.31
13.18
36.65
33.38
9.98

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
47.47
48.51
47.36
50.66
49.28
47.21
44.89
42.54
41.11
41.34
ROA
-1.06%
1.05%
-2.93%
1.19%
1.75%
1.97%
2.15%
2.14%
2.70%
2.66%
ROE
-2.25%
2.33%
-6.67%
2.84%
4.40%
5.06%
5.64%
5.78%
7.17%
6.92%
ROCE
1.97%
5.77%
1.41%
8.32%
10.29%
9.13%
9.73%
9.95%
11.58%
12.24%
Fixed Asset Turnover
1.12
1.23
1.15
1.76
2.11
1.48
1.27
1.26
1.25
1.33
Receivable days
75.92
77.89
79.75
65.92
68.64
96.93
103.72
95.49
85.98
77.54
Inventory Days
139.23
118.26
161.98
130.89
104.21
149.46
176.99
165.71
161.85
153.20
Payable days
109.47
107.25
137.11
82.45
68.84
113.92
128.03
119.13
113.39
105.76
Cash Conversion Cycle
105.68
88.90
104.62
114.37
104.01
132.47
152.69
142.07
134.44
124.98
Total Debt/Equity
0.71
0.79
0.85
0.69
0.82
0.90
0.87
1.01
1.00
0.93
Interest Cover
0.47
1.43
0.24
1.30
1.40
1.54
1.57
1.52
1.67
1.57

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • Nectar Lifesciences - Quarterly Results
    14th Aug 2023, 13:28 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.